Skip to main content
California Medicine logoLink to California Medicine
. 1953 Oct;79(4):300–305.

VERATRUM VIRIDE—Hypotensive and Cardiac Effects of Intravenous Use

Stephen R Elek, J Douglas McNair, George C Griffith
PMCID: PMC1521946  PMID: 13094542

Abstract

The hypotensive action of veratrum viride given intravenously was studied in 24 patients, 22 of them hypertensive and 2 normotensive. Vasodepression of considerable but variable degree was obtained in all patients. Maximum hypotension occurred 8 to 15 minutes after injection and relative hypotension usually lasted at least two hours.

In four patients subnormal hypotension occurred but there were no clinical manifestations of shock. The blood pressure rose promptly when pressor drugs were administered.

A dose of 0.3 to 0.5 mg. brought about a satisfactory decrease in blood pressure. The degree of decrease was affected by the speed of administration and in a few patients by idiosyncratic sensitivity to the drug.

Veratrum has an extravagal action on the pulse rate, and in that and other respects resembles digitalis. Veratrum should be given with caution to digitalized patients.

Atropine reduced but did not abolish the hypotensive effect of veratrum, and was more effective when given before veratrum. This indicates that the parasympathomimetic action of veratrum is important in the mechanism of blood pressure reduction.

Full text

PDF
300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARROW J. G., SIKES C. R. The use of purified veratrum viride alkaloids in the treatment of essential hypertension. Am Heart J. 1951 May;41(5):742–748. doi: 10.1016/0002-8703(51)90263-3. [DOI] [PubMed] [Google Scholar]
  2. ELEK S. R., MCNAIR J. D., GRIFFITH G. C. The electrocardiographic effects of intravenous veratrum viride. Circulation. 1953 Jun;7(6):903–909. doi: 10.1161/01.cir.7.6.903. [DOI] [PubMed] [Google Scholar]
  3. FREIS E. D., STANTON J. R. The hemodynamic effects of hypotensive drugs in man; dihydroergocornine. J Clin Invest. 1949 Nov;28(6 Pt 2):1387–1402. doi: 10.1172/JCI102204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freis E. D., Stanton J. R., Culbertson J. W., Litter J., Halperin M. H., Burnett C. H., Wilkins R. W. THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. I. VERATRUM VIRIDE. J Clin Invest. 1949 Mar;28(2):353–368. doi: 10.1172/JCI102078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MEILMAN E., KRAYER O. Clinical studies on veratrum alkaloids; the action of protoveratrine and veratridine in hypertension. Circulation. 1950 Feb;1(2):204–213. doi: 10.1161/01.cir.1.2.204. [DOI] [PubMed] [Google Scholar]
  6. McNAIR J. D., GRIFFITH G. C., ELEK S. R. A prolonged study of oral veratrum viride in the treatment of essential hypertension. Am Heart J. 1950 Sep;40(3):382–389. doi: 10.1016/0002-8703(50)90321-8. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES